EGFR-dependent tumours through the EV cargo of specific proteins, mRNAs, or miRNAs can modulate long-distance and organ-specific cells by promoting growth and invasion, regulating TME, and conferring drug resistance. This evidence concerns the gene EGFR and neoplasm.